| Product Name | MF | CAS | Details |
|---|
| SLC15A2 Blocking Peptide | Details |
| H-LDVHYAPTIR^-OH | Details |
| 4-(4-methylphenyl)-1-(2-(4-(trifluoromethoxy)phenoxy)acetyl)thiosemicarbazide | C17H16F3N3O3S | 1024449-08-8 | Details |
| 2-(Furan-2-yl)propan-2-ol | C7H10O2 | 6378-58-1 | Details |
| 4-Fluoro-2,3-dihydro-1-benzofuran-3-amine hydrochloride | C8H9ClFNO | 1384265-54-6 | Details |
| 1-Ethyl-5-(trifluoromethyl)-1H-pyrazole | C6H7F3N2 | 1392274-30-4 | Details |
| RPL26L antibody | Details |
| 2,6-Dichloroquinoline-4-carbonitrile | C10H4Cl2N2 | 50504-14-8 | Details |
| 9-Bromo-8-fluoro-1H,2H,4H,4aH,5H,6H-morpholino[4,3-a]quinoxalin-5-one | C11H10BrFN2O2 | 1706683-14-8 | Details |
| Bis[3-(triethoxysilyl)propyl]-disulfide | C18H42O6S2Si2 | 56706-10-6 | Details |
| Ethyl indole-6-carboxylate | C11H11NO2 | 50820-64-9 | Details |
| (2R)-3-(4-phenylpiperazin-1-yl)propane-1,2-diol | C13H20N2O2 | 99291-24-4 | Details |
| tert-Butyl 4-hydroxybenzylcarbamate | C12H17NO3 | 149505-94-2 | Details |
| 2,5-Dioxopyrrolidin-1-yl formate | C5H5NO4 | 17592-54-0 | Details |
| 1,1-Dimethyl 2-methylcyclopropane-1,1-dicarboxylate | C8H12O4 | 97935-32-5 | Details |
| 5-Oxo-5-{4-[4-(propan-2-yl)benzenesulfonyl]piperazin-1-yl}pentanoic acid | C18H26N2O5S | 888103-33-1 | Details |
| 1-(2-Aminobenzoyl)piperidine-4-carboxamide | C13H17N3O2 | 953886-87-8 | Details |
| Ethyl 3,3-difluoroprop-2-enoate | C5H6F2O2 | 407-35-2 | Details |
| (2-Methoxyphenyl)(piperazin-1-yl)methanone hydrochlorde | C12H17ClN2O2 | 100939-98-8 | Details |
| 2-Cyclopentyl-4,5,6,7-tetrahydro-2H-indazol-7-amine | C12H19N3 | 1461705-82-7 | Details |
| Hypocrellin A | C30H26O10 | 77029-83-5 | Details |
| N-Boc-2-(1-aminocyclopentyl)acetic acid | C12H21NO4 | 282525-00-2 | Details |
| 2-Bromo-N,2-dimethylpropanamide | C5H10BrNO | 69959-88-2 | Details |
| 2-(Quinolin-4-yl)ethan-1-ol | C11H11NO | 55908-35-5 | Details |
| H-VMAPRTLIL-OH | Details |
| 5-(4-Fluorophenoxy)pyridin-2-amine | C11H9FN2O | 672945-75-4 | Details |
| 3-(Methylamino)-1-(2,2,2-trifluoroethyl)pyrrolidin-2-one | C7H11F3N2O | 1247519-63-6 | Details |
| Polyhexamethylene biguanide hydrochloride - Solid | (C8H17N5)n.xClH | 32289-58-0 | Details |
| 6-Nitrophthalide | C8H5NO4 | 610-93-5 | Details |
| 2-[4-({[(9H-Fluoren-9-yl)methoxy]carbonyl}amino)oxan-3-yl]acetic acid | C22H23NO5 | 2138185-27-8 | Details |
| COMMD1 Blocking Peptide | Details |
| 5,6,7,8-Tetrahydronaphthalene-2-carbaldehyde | C11H12O | 51529-97-6 | Details |
| 7-Methoxy-1,2-dihydrophthalazin-1-one | C9H8N2O2 | 60889-22-7 | Details |
| b-D-Galactose-sp-biotin | Details |
| ZNF550 Blocking Peptide | Details |
| [(1-Phenyl-1H-pyrazol-4-yl)methyl](propan-2-yl)amine | C13H17N3 | 1152898-13-9 | Details |
| H-VEGAGEEQAAK-OH | Details |
| Eszopiclone Impurity B | C11H7ClN4O2 | 43200-81-3 | Details |
| (Methacryloxypropyl)methylsiloxane-dimethylsiloxanecopolymers | 104780-61-2 | Details |
| 3-(4-Chloro-3-nitrophenyl)-1,3-oxazolidin-2-one | C9H7ClN2O4 | 104679-38-1 | Details |
| HIV - 1 MN ENV - 26 | C80H122N20O28S | Details |
| 2-{3-[2-(Dimethylamino)ethoxy]phenyl}acetic acid hydrochloride | C12H18ClNO3 | 1607256-31-4 | Details |
| N-(3-Acetylphenyl)-4-ethoxypiperidine-1-carboxamide | C16H22N2O3 | 1304896-88-5 | Details |
| 2-(3-Cyclopropyl-1-methyl-1H-1,2,4-triazol-5-yl)acetonitrile | C8H10N4 | 1909326-95-9 | Details |
| BDNF Blocking Peptide | Details |
| FUNDC1 Blocking Peptide | Details |
| 2-(5-Methoxy-1,3,4-thiadiazol-2-yl)acetonitrile | C5H5N3OS | 84389-19-5 | Details |
| Z-Phe-Arg-pNA·HCl | C29H34ClN7O6 | 59188-54-4 | Details |
| 3-Methanesulfonylbenzoyl chloride | C8H7ClO3S | 54857-54-4 | Details |
| WDR45 antibody | Details |
| [Tyr12]-Somatostatin-28 (1-14) | C65H107N23O20S | Details |
| (+)-Pinoresinol | C20H22O6 | 487-36-5 | Details |
| Z-Gly-Gly-Arg-MCA | Details |
| H-HTSVQTTSSGSGPFTDVR^-OH | Details |
| H-NLPQQCGLR^-OH | Details |
| Influenza HA (518-526) | C42H69N9O15 | 186302-15-8 | Details |
| Ethyl 5-chloro-4-hydroxy-8-methoxyquinoline-3-carboxylate | C13H12ClNO4 | 27333-34-2 | Details |
| Simvastatin hydroxy acid ethyl ester | C27H44O6 | 864357-87-9 | Details |
| Benzothiazole-5-boronic acid pinacol ester | C13H16BNO2S | 1073354-91-2 | Details |
| ACTA1 antibody | Details |
| 5-Bromo-N-methanesulfonylpentanamide | C6H12BrNO3S | 52533-64-9 | Details |
| FR 171113 | C19H11Cl3N2O4S | 173904-50-2 | Details |
| Methyl 4-{[N-(pyridin-3-ylmethyl)4-methoxybenzenesulfonamido]methyl}benzoate | C22H22N2O5S | 1000931-00-9 | Details |
| LYN-1604 | C33H43Cl2N3O2 | 2088939-99-3 | Details |
| SNAPC5 antibody | Details |
| tert-Butyl 5-(aminomethyl)-hexahydro-2H-furo[3,2-b]pyrrole-4-carboxylate | C12H22N2O3 | 2155851-93-5 | Details |
| 5-Bromo-1H-pyrrolo[2,3-b]pyridine-3-sulfonamide | C7H6BrN3O2S | 1936017-68-3 | Details |
| H-YTIAALLSPYSYSTTAVVTNPK^E-OH | Details |
| H-FQNALLVR^-OH | Details |
| 2,5-Dihydro-1H-pyrrole-2-carboxylic acid hydrochloride | C5H8ClNO2 | 1841081-26-2 | Details |
| EXTL3 antibody (HRP) | Details |
| Methyl (2Z)-3-[(2,4-difluorophenyl)sulfanyl]prop-2-enoate | C10H8F2O2S | 1563970-41-1 | Details |
| N1-[4-(Allyloxy)phenyl]acetamide | C11H13NO2 | 6622-73-7 | Details |
| 5-(Chloromethyl)-3-methyl-1,2,4-thiadiazole | C4H5ClN2S | 163009-79-8 | Details |
| 2-(3-Methyl-2,4-dioxoimidazolidin-1-yl)acetic acid | C6H8N2O4 | 64942-72-9 | Details |
| N-[2-[(4-Chlorophenyl)thio]phenyl]-carbamic acid phenyl ester | C19H14ClNO2S | 1544636-74-9 | Details |
| 6-Chloro-9-(2',3'-O-isopropylidene-b-D-ribofuranosyl)purine | C13H15ClN4O4 | 39824-26-5 | Details |
| [(2,5-Difluorophenyl)methyl][(1,3-dimethyl-1H-pyrazol-4-yl)methyl]amine | C13H15F2N3 | 1006449-75-7 | Details |
| 4-Phenylpyridin-3-ol | C11H9NO | 101925-26-2 | Details |
| 2-(3-Methylcyclopentyl)ethan-1-amine hydrochloride | 2228336-68-1 | Details |
| rec Endothelial IL-8 (human) | 142298-01-9 | Details |
| Methyl 3-amino-2-[(2-methylphenyl)methyl]propanoate hydrochloride | C12H18ClNO2 | 1258640-06-0 | Details |
| 1-[(6-Chloropyridin-3-yl)methyl]-2,3-dihydro-1H-imidazol-2-one | C9H8ClN3O | 223380-78-7 | Details |
| Mouse IGFBP2 ELISA kit | Details |
| 1-(3-Aminopropyl)cyclobutan-1-ol | C7H15NO | 1428235-39-5 | Details |
| H-MLAVISCAV-OH | Details |
| 1-(4-Bromophenyl)-2-methylpropan-1-amine | C10H14BrN | 785762-36-9 | Details |
| 8-Methyl-5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyrazine | C6H10N4 | 1174644-89-3 | Details |
| Plakophilin 1 antibody | Details |
| H-GPSVFPL^APSSK-OH | Details |
| 3-{2-[(tert-Butyldimethylsilyl)oxy]-4-hydroxyphenyl}-1-(pyrrolidin-1-yl)propan-1-one | C19H31NO3Si | 2219380-11-5 | Details |
| 1-(Piperidine-4-carbonyl)pyrrolidine-2-carboxamide hydrochloride | C11H20ClN3O2 | 1231925-79-3 | Details |
| A3 N-Glycan | C109H187N11O80 | 145164-24-5 | Details |
| Ac-HHHHHHC-OH | Details |
| MLF1 antibody | Details |
| 7-Chloro-2(1H)-quinoxalinone | C8H5ClN2O | 59489-30-4 | Details |
| (-)-Oxypeucedanin | C16H14O5 | 26091-73-6 | Details |
| 2-[(2,2,2-Trifluoroethyl)carbamoyl]acetic acid | C5H6F3NO3 | 1248985-24-1 | Details |
| 10(Z),13(Z)-Nonadecadienoic acid | C19H34O2 | 29204-20-4 | Details |
| H-Trp-Lys-Tyr-Met-Val-D-Met-NH2 trifluoroacetate salt | Details |
| Product Total： Product Page： | ||||
| 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 | ||||